| 中医药治疗高血压心肌纤维化的研究 |
| |
| 引用本文： | 吕仕超,杨锡燕,张军平. 中医药治疗高血压心肌纤维化的研究[J]. 世界科学技术-中医药现代化, 2015, 17(6): 1295-1299 |
| |
| 作者姓名： | 吕仕超 杨锡燕 张军平 |
| |
| 作者单位： | 天津中医药大学第一附属医院 天津 300193,天津中医药大学第一附属医院 天津 300193,天津中医药大学第一附属医院 天津 300193 |
| |
| 基金项目： | 教育部高等学校博士学科点专项科研基金博导类资助课题（20111210110003）：TGF-β1/Smads通路在不同原因导致的心肌纤维化中差异表达及中药调控机制研究，负责人：张军平；国家中医药管理局中医药行业科研专项（201007003-03）：中医药防治高血压的优势评估与转化应用-高血压中医临床科研共享信息平台的应用研究，负责人：杨锡燕。 |
| |
| 摘 要： | 心肌纤维化是高血压性心脏病的病理基础，是控制高血压心血管并发症的关键。现代医学只是针对单一的病理环节进行干预，中医药具有多成分、多途径、多靶点综合干预的优势，从不同的角度探讨中医药干预高血压心肌纤维化的效应和机制，可为高血压心肌纤维化的临床治疗提供参考。
|
| 关 键 词： | 高血压 心肌肥厚 心肌纤维化 中医药 |
| 收稿时间： | 2014-10-30 |
| 修稿时间： | 2014-11-13 |
Research on Treatment of Myocardial Fibrosis in Hypertension with Traditional Chinese Medicine |
| |
| Lv Shichao,Yang Xiyan and Zhang Junping. Research on Treatment of Myocardial Fibrosis in Hypertension with Traditional Chinese Medicine[J]. World Science and Technology—Modernization of Traditional Chinese Medicine and Materia Medica, 2015, 17(6): 1295-1299 |
| |
| Authors: | Lv Shichao Yang Xiyan Zhang Junping |
| |
| Affiliation: | The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China |
| |
| Abstract: | Myocardial fibrosis is the pathological basis of hypertensive heart disease, which is the key to control cardiovascular complications. Traditional Chinese medicine (TCM) has the advantage of targeting many components of a system and providing more integrated regulation than modern medicine. While, modern medicine tends to target a single pathological link. This study was aimed to investigate effects and mechanisms in the treatment of myocardial fibrosis in hypertension with TCM from a different perspective, which provided references for clinical treatment. |
| |
| Keywords: | Hypertension cardiac hypertrophy myocardial fibrosis traditional Chinese medicine |
|
| 点击此处可从《世界科学技术-中医药现代化》浏览原始摘要信息 |
|
点击此处可从《世界科学技术-中医药现代化》下载全文 |
